Reweaving Loose Threads

For individuals who develop a psychotic disorder such as schizophrenia, the first episode of psychosis most often occurs during late adolescence or early adulthood. Research shows that what happens during this early window can shape the course of illness for years to come.

At Sheppard Pratt, early identification and intervention after a first episode of psychosis (FEP) are viewed as essential opportunities to change long-term outcomes. According to Paul Fuchs, MD, MPH, service chief for the young adult unit at Sheppard Pratt’s Towson campus, one of the most important predictors of prognosis is the duration of untreated psychosis. The longer symptoms go unrecognized or untreated, the more likely future episodes are to become severe and difficult to manage.

Schizophrenia spectrum disorders typically emerge in the early 20s, with males often presenting slightly earlier than females. Early episodes within the schizophrenia spectrum are frequently diagnostically complex. Symptoms may resemble those of bipolar disorder with psychotic features, major depressive disorder with psychosis, substance-induced psychosis, trauma-related disorders, or organic medical conditions. For this reason, Dr. Fuchs emphasizes the importance of comprehensive assessment, including psychiatric evaluation, medical and medication review, laboratory testing, and, when indicated, neuroimaging and EEG.

Clinicians are also seeing increased complexity related to substance use, particularly cannabis. While causality is difficult to establish, cannabis exposure appears to be common among young adults presenting with psychosis and may exacerbate symptoms in biologically vulnerable individuals.

Evidence consistently shows that each untreated psychotic episode increases the risk of relapse and functional decline. Early intervention seeks to interrupt this trajectory by stabilizing symptoms quickly; minimizing neurobiological stress; and preserving social, educational, and vocational functioning.

This approach is supported by landmark research, including the Recovery After an Initial Schizophrenia Episode (RAISE) initiative. Launched in 2008, RAISE was a large-scale, federally funded research program designed to evaluate coordinated specialty care for individuals experiencing early psychosis. The initiative sought to identify the most effective ways to support recovery, reduce the likelihood of future episodes, and limit long-term disability. Findings from RAISE helped establish early psychosis care as a time-sensitive intervention, rather than a delayed response to chronic illness.

Modern treatment for FEP is increasingly personalized, collaborative, and recovery oriented. Medication remains a cornerstone of care, but best practice emphasizes using the lowest effective dose, minimizing side effects, and engaging patients as active partners in treatment. Long-acting injectable medications may be appropriate for some individuals, though decisions must be made thoughtfully to balance adherence, tolerability, and trust.

Equally important are step-down and transitional services that extend care beyond inpatient settings. At Sheppard Pratt, individuals may move from inpatient stabilization to specialized day hospital programs, residential services, and outpatient care, staying connected to clinicians experienced in early psychosis.

The message is clear: Early, coordinated treatment after a first episode of psychosis can change the course of illness. By identifying symptoms promptly, involving families, individualizing care, and supporting functional recovery, clinicians can help young adults maintain independence and quality of life. Grounding its care in evidence and guided by clinical expertise, Sheppard Pratt remains committed to advancing early psychosis care so that early intervention leads not just to stabilization, but to lasting recovery.